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DNase Sda1 provides selection pressure for a switch to invasive group A
streptococcal infection
Abstract
Most invasive bacterial infections are caused by species that more commonly colonize the human host
with minimal symptoms. Although phenotypic or genetic correlates underlying a bacterium’s shift to
enhanced virulence have been studied, the in vivo selection pressure governing such shifts are poorly
understood. The globally disseminated M1T1 clone of group A Streptococcus (GAS) is linked with rare but
life-threatening syndromes of necrotizing fasciitis and toxic shock syndrome. Mutations in the GAS
control of virulence regulatory sensor kinase (covRS) operon are associated with severe invasive disease,
abolishing expression of a broad spectrum cysteine protease (SpeB)2,3 and allowing the recruitment and
activation of host plasminogen on the bacterial surface. Here we describe how bacteriophage-encoded
GAS DNase (Sda1), which facilitates the pathogen’s escape from neutrophil extracellular traps (NETs)5,6,
serves as a selective force for covRS mutation. The results provide a paradigm whereby natural selection
exerted by the innate immune system generate hypervirulent bacterial variants with increased risk of
systemic dissemination.
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Most invasive bacterial infections are caused by species that more commonly
colonize the human host with minimal symptoms. Although phenotypic or
genetic correlates underlying a bacterium’s shift to enhanced virulence have
been studied, the in vivo selection pressure governing such shifts are poorly
understood. The globally disseminated M1T1 clone of group A Streptococcus
(GAS) is linked with rare but life-threatening syndromes of necrotizing fasciitis
and toxic shock syndrome1. Mutations in the GAS control of virulence
regulatory sensor kinase (covRS) operon are associated with severe invasive
disease, abolishing expression of a broad spectrum cysteine protease (SpeB)2,3
and allowing the recruitment and activation of host plasminogen on the bacterial
surface4. Here we describe how bacteriophage-encoded GAS DNase (Sda1),
which facilitates the pathogen’s escape from neutrophil extracellular traps
(NETs)5,6, serves as a selective force for covRS mutation. The results provide a
paradigm whereby natural selection exerted by the innate immune system
generate hypervirulent bacterial variants with increased risk of systemic
dissemination.

GAS is estimated to cause ~700 million cases of self-limited throat or skin infection
each year worldwide7. Invasive GAS disease occurs in approximately 1/1,000 cases,
with associated mortality of 25%7. Epidemic invasive disease is associated with the
emergence of the globally disseminated GAS M1T1 clone1,8, which is distinguished
from related strains by acquisition of prophages encoding virulence determinants such
as superantigen SpeA and DNase Sda19,10. In the M1T1 GAS clone, the transition
from local to systemic infection can be linked to mutations in the two-component
covRS regulator. The effect of these mutations is a distinct shift in the transcriptional
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profile of invasive GAS isolates compared to mucosal (throat) isolates3. The covRS
mutation and changes in gene expression are recapitulated upon subcutaneous
challenge of mice and analysis of GAS disseminating to the spleen in comparison
with those in the original inocolum3. Prominent changes in the transcriptional profile
of invasive GAS isolates include a strong up-regulation of the DNase gene sda1, and
a marked decrease in expression of the gene encoding the cysteine protease SpeB3.
Sda1 is a virulence factor that protects GAS against neutrophil killing by degrading
the DNA framework of NETs5,6. Abolishment of SpeB expression allows
accumulation and activation of the broad spectrum host protease plasmin on the GAS
bacterial surface4. A clinical correlation of GAS invasive disease severity and
diminished SpeB expression has been established2.

To elucidate the selection pressure for the rapid loss of SpeB expression in vivo, we
have compared the human M1T1 GAS isolate 5448 and its isogenic animal passaged
SpeB-negative variant 5448AP11. DNA sequence analysis shows 5448AP contains a
single adenine base insertion at position 877 of the covS gene (Fig. 1a) and lacks
SpeB production (Fig. 1b). Whilst equivalent to wild-type (WT) 5448 in expression
of plasminogen receptors α-enolase12 and GAPDH13, 5448AP exhibits higher levels
of the fibrinogen-binding M1 protein14,15 and streptokinase (Fig. 1c). Although
washed 5448 and 5448AP cells bind identical levels of human plasminogen (Fig. 1d),
5448AP accumulates significantly higher levels of surface plasmin activity following
growth in human plasma (P < 0.05; Fig. 1e). The observed phenotypes of 5448AP
parallel those seen upon allelic replacement of the speB gene in the parent strain
(mutant 5448ΔspeB4), indicating that surface plasmin acquisition by 5448AP reflects
the loss of SpeB. Additionally, other gene expression changes, such as the increase in
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streptokinase expression associated with covRS mutation3, may also contribute to
surface plasmin acquisition by 5448AP (Supplementary Fig. 1). Compared to WT,
the 5448AP strain was found to be hypervirulent in a humanized plasminogen mouse
subcutaneous infection model (P < 0.05; Fig. 1f and Supplementary Fig. 2). Isogenic
mutagenesis of 5448AP was undertaken to construct a streptokinase-deficient strain
(5448APΔska), which showed reduced virulence in comparison to 5448AP (P < 0.05;
Fig. 1f). This observation is consistent with the reduced virulence of ska-deficient
GAS previously reported16. Enumeration of bacterial counts in the site of infection,
blood, spleen and liver of humanized plasminogen mice, suggest that the enhanced
virulence of strain 5448AP is as a result of a widespread systemic infection following
breakout from the site of local infection, immediately prior to the death of the mice
(Fig. 1g). These humanized animal model data reflect observations made in the
clinical setting for GAS M1T1 strains, where mutations in covRS correlate with
human invasive disease severity2,3.

Next, infection chambers were implanted subcutaneously in mice and inoculated with
either GAS 5448 or 5448AP. After 24 h, bacteria were recovered and analyzed for
SpeB and Sda1 expression. Quantitative real-time PCR analysis reveals speB
expression is down-regulated over 10,000× in 5448AP, when compared to WT 5448
(Fig. 2a). In contrast, an over 5× up-regulation of sda1 gene expression was observed
by 24 h in 5448 following in vivo growth, which matched the increased DNase
expression levels seen in vivo for 5448AP (Fig. 2b and Supplementary Fig. 3a).
DNA degradation by 5448AP was increased compared to the GAS 5448 parent strain
(Fig. 2c and Supplementary Fig. 3b), consistent with both the up-regulation of sda1
expression and the known ability of SpeB to degrade Sda111. Compared to the 5448
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parent strain, the enhanced DNase activity of 5448AP was associated with clearance
of NETs (Fig. 2d and Supplementary Fig. 4a) and increased resistance to neutrophil
killing (Fig. 2e). Neither streptokinase nor M1 protein contribute to NET clearance
(Supplementary Fig. 4b).

Neutrophils and NET-mediated extracellular killing play a pivotal role in antibacterial
clearance at the initial site of infection5,17. We hypothesized that acquisition of the
potent bacteriophage-encoded DNase Sda1 by the M1T1 clone provides the selective
force for loss of SpeB expression in vivo, since the cysteine protease is capable of
degrading this important neutrophil survival factor. To examine this possibility, we
subcutaneously challenged C57BL/J6 mice separately with 5448 and the isogenic
5448Δsda1 mutant, predicting that absence of Sda1 would reduce the selective
advantage for mutation to a SpeB-negative phenotype. Loss of SpeB expression in
vivo during subcutaneous mouse infection was abrogated in the isogenic 5448Δsda1
mutant compared to WT 5448 (Fig. 2f; 1/500 SpeB-negative 5448Δsda1 colony
versus 76/500 SpeB-negative 5448 colonies; P < 0.05). DNA sequence analysis of 10
selected SpeB-negative 5448 colonies suggests that mutations in covRS have resulted
in loss of SpeB expression (Supplementary Table 1), as previously reported3. We
used reverse complementation to replace the mutated chromosomal locus in
5448Δsda1 with the WT allele to construct 5448RCsda1+. This complemented mutant
regained the capacity to switch to the SpeB-negative phenotype (Fig. 2f; 45/500
SpeB-negative 5448RCsda1+ colonies; P = 0.39). The isogenic mutant 5448Δsmez,
derived in a manner identical to 5448Δsda1, was found to retain the capacity to phaseswitch similar to the WT strain 5448 (Fig. 2f; 33/500 SpeB-negative 5448Δsmez
colonies; P = 0.11). These observations suggest that the phase-switching phenotype is
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due to allelic replacement of the sda1 gene and not due to the methodology used to
construct an isogenic GAS mutant in strain 5448. The M1 serotype GAS strain SF370
is known not to encode Sda19,10. SF370 was found to have minimal capacity to switch
to the SpeB-negative phenotype compared to 5448 (Fig. 2f; 2/500 SpeB-negative
SF370 colonies; P < 0.05) consistent with the absence of Sda1 and thus lack of
selective advantage for mutation to the SpeB-negative phenotype.

The globally disseminated Streptococcus pyogenes M1T1 clone emerged in the mid1980s as a major cause of severe GAS invasive disease. Recent genome-scale
analyses have found that in comparison to other M1 strains, the M1T1 clone has
acquired two lysogenised bacteriophage genomes encoding Sda1 and SpeA,
respectively9,10. While the introduction of SpeA into the GAS population increases the
propensity to cause streptococcal toxic shock, this study has shown that positive
selection pressure in vivo is placed upon the bacteriophage-encoded virulence
determinant Sda1. Loss of SpeB spares Sda1 from degradation11 and improves GAS
resistance against neutrophil clearance. In vivo, the phase-shift in SpeB expression is
abrogated by isogenic mutagenesis of sda1. The genetic basis for loss of SpeB
expression has been previously described3. Loss of SpeB has also been shown to
result in increased invasive propensity of M1T1 by the accumulation of surface-bound
plasmin activity4. Therefore, we hypothesize that the bacteriophage-mediated
acquisition of the sda1 gene by the ancestral M1T1 has provided evolutionary
selection pressure for increased neutrophil resistance via SpeB loss, which results in a
hyperinvasive phenotype and can lead to severe invasive disease progression (Fig. 3).
The evolution of bacterial pathogens principally occurs either through deletion events
or horizontal gene transfer and acquisition18, which is exemplified by the
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bacteriophage-mediated acquisition of the sda1 gene by M1T1. These data provide a
paradigm for bacteriophage-mediated acquisition of virulence determinants and
development of severe disease by otherwise benign human pathogens.
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Figure legends:

Fig. 1. Molecular and phenotypic analyses of GAS strains 5448 and 5448AP. (a)
DNA sequence comparison of GAS strains 5448 and 5448AP confirms the presence
of a 1 base adenine addition at the 3’ end of covS (nt position 877) encoded by
5448AP (unfilled arrowhead). Primers used for DNA sequence analysis are indicated
by filled arrowheads (p1 to p12). This insertion mutation results in the truncation of
the CovS open reading frame at amino acid 300 from the CovS methionine start
codon. Putative conserved CovS domains are indicated in lower panel: HAMP:
Histidine kinases/adenylyl cyclases/methyl-binding proteins/phosphatases; HisKA,
Histidine kinase domain (phosphoacceptor); HATPase: Histidine kinase-like ATPase.
Scales, in base pairs (bp; upper panel bar) and amino acids (aa; lower panel bar), are
indicated. (b) In comparison to GAS strain 5448, secreted SpeB protease activity is
abrogated in 5448AP (n = 3; mean ± SD). Asterisk indicates statistically significant
difference from 5448, where P < 0.05. (c) Western blot analysis of cell wall extracts
indicates that equivalent amounts of α-enolase (unfilled arrowhead) and GAPDH
(unfilled arrowhead) are produced by strains 5448 and 5448AP, whereas higher
amount of M1 protein (unfilled arrowhead) is produced in cell wall extracts and
streptokinase (unfilled arrowhead) is secreted into culture supernatants by strain
5448AP, in comparison to 5448. Molecular mass markers (MWT) are given in kiloDaltons (kDa). (d) Washed 5448 and 5448AP cells bind equivalent amounts of human
plasminogen (n = 3; mean ± SD). (e) Following overnight growth at 37 oC in human
plasma, 5448AP accumulates significantly higher levels of surface plasmin activity (n
= 3; mean ± SD). Asterisk indicates statistically significant difference from 5448,
where P < 0.05. (f) Survival curves following subcutaneous infection of humanized
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plasminogen transgenic mice (n = 10) with GAS strain 5448 (3.2 × 108 colony
forming units/dose; solid line), 5448AP (1.6 × 108 colony forming units/dose; dashed
line) and 5448APΔska (1.5 × 108 colony forming units/dose; dotted line). (g)
Enumeration of bacterial counts in the site of infection, blood, spleen and liver of
humanized plasminogen mice (n = 5) subcutaneously infected with GAS strain 5448
(2.6 × 107 colony forming units/dose; open circles) and 5448AP (4.9 × 107 colony
forming units/dose; filled circles).

Fig. 2. Relative expression of (a) the speB gene and (b) the sda1 gene, as determined
using quantitative real-time PCR (n = 3; mean ± SD). RNA was extracted from GAS
either immediately prior to inoculation (0 h) or 24 h post-inoculation of subcutaneous
infection chambers. Asterisk indicates statistically significant difference from 5448 (0
h), where P < 0.05. (c) DNase expression in GAS mid-logarithmic phase culture
supernatants as assessed by degradation of calf thymus DNA (control). (d) Clearance
of NETs by GAS. Neutrophils were visualized using bright field microscopy, whilst
NETs were visualized using Sytox Orange staining. Scale bar = 100 μm. (e) Killing of
GAS by human neutrophils at a multiplicity of infection (GAS:neutrophils) = 1:10 (n
= 3; mean ± SD). Asterisk indicates statistically significant difference from 5448,
where P < 0.05. (f) The capacity of GAS strains 5448, 5448Δsda1, 5448RCsda1+,
5448Δsmez and SF370 to phase-shift to a SpeB-negative phenotype was examined 3 d
post-subcutaneous infection of mice.

Fig. 3. Model for group A streptococcal invasive disease initiation and progression.
(a) Following entry via the skin, GAS (blue) are able to express SpeB (required
during the early stages of the infection process; black dots). An innate immune
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response is mounted by host neutrophils and entrapment of GAS in NETS (orange)
begins. (b) Within the GAS population, a mutation in covRS occurs (green), resulting
in loss of SpeB expression and improved resistance to killing by neutrophils. (c)
Selection pressure by neutrophils results in an increase in the proportion of covRS
mutant phenotype GAS within the bacterial population, improved NET clearance and
neutrophil resistance. (d) Loss of SpeB expression allows the accumulation of surface
plasmin activity leading to systemic infection.
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Supplementary Table 1. CovRS DNA sequence analysis of selected GAS
M1T1 strain 5448 SpeB-negative derivatives isolated 3 d following
subcutaneous infection of C57BL/J6 mice.
GAS strain
5448-APD1
5448-APD2
5448-APD3
5448-APD4
5448-APD5
5448-APD6
5448-APD7
5448-APD8
5448-APD9
5448-APD10

Mouse ID
OS41B
OS41B
OS41B
OS45R
OS45R
OS46L
OS46L
OS46L
OS322B
OS492L

Tissuea
Blood
Lesion
Lesion
Blood
Blood
Lesion
Lesion
Lesion
Lesion
Lesion

Mutationb
C to T nt 838 covS
C to T nt 838 covS
C to T nt 838 covS
C to T nt 838 covS
C to T nt 838 covS
Δ nt 83 covS
Δ nt 83 covS
G to A nt 331 covR
Δ nt 406-1503 covS
C to T nt 838 covS

Consequencec
H to Y aa 280 covS
H to Y aa 280 covS
H to Y aa 280 covS
H to Y aa 280 covS
H to Y aa 280 covS
Truncation in CovS
Truncation in CovS
A to T aa 111 covR
Truncation in CovS
H to Y aa 280 covS

Mouse tissue from which GAS strain was isolated 3 d post-subcutaneous
infection.
b
Mutation positions are based upon nucleotide (nt) position in the covR or
covS genes, relative to each ATG start codon.
c
Substitutions in CovR and CovS are based upon amino acid (aa) position in
each open reading frame, relative to each start codon.
a

Supplementary Table 2. Oligonucleotide primers used in this study for
construction of recombinant GAS strains.
Primer
RCSdapHY304Fwd
RCSdapHY304Rev
SdaF2
SdaR4
SmeZ-UpF
SmeZ-UpR

Direction
Forward
Reverse
Forward
Reverse
Forward
Reverse

bp
29
28
21
20
20
54

SmeZ-DownF

Forward

54

SmeZ-DownR
Emm1-dis-F-BamHI
Emm1-dis-R-XbaI
M1ska-dis-F-BamHI
M1ska-dis-R-XbaI
T7-For
Emm1out-R
M1skaout-R

Reverse
Forward
Reverse
Forward
Reverse
Forward
Reverse
Reverse

20
30
30
30
21
24
24

Sequence
GGGCTGCAGCTTAAACGTTGGTATTTTTA
GGGGAATTCGGATAGCTTACAACTAGTG
ATGTCTAAACATTGGAGACAT
ATCAGATGATAAAGCAGACA
TGGCTGACAACTGTCAGGAA
GGTGGTATATCCAGTGATTTTTTTCTCCATAAATAGCCT
CTTTTCAGGAGTTAT
TACTGCGATGAGTGGCAGGGCGGGGCGTAATTCAATTT
TTCAATATAACTTTTA
AACGACACCTCTTTCAGCGA
GCGGATCCTAGTCCTGACTCGCTTGGTCTA
GCATCTAGACTTGCAGCAAACAATCCCGCA
GCGGATCCAACATCACAACCTGCTCACGGA
GCGTCTAGACGCGCACATGTCCCTTTAACAA
GTAATACGACTCACTATAGGG
GAGGTTAAGGCTAACGGTGATGGT
TTGAGCCCTGGTCTGAAATCGTCA

Supplementary Table 3. Oligonucleotide primers used in this study for
covRS PCR and sequence analysis.
Primer
p1
p2
p3
p4
p5
p6
p7
p8
p9
p10
p11
p12

Direction
Forward
Forward
Forward
Forward
Forward
Forward
Reverse
Reverse
Reverse
Reverse
Reverse
Reverse

bp
19
19
22
22
20
21
20
20
21
21
21
19

Sequence
GCTATTCCGGTACAGGTCT
GTCAATGGTCGTGAAGGGT
GATGTCTATATTCGTTATCTCC
GATGATTTTTACCACAGATAAC
GCATATTGGTCTCTTACAAC
GCAAATTGTAGATGGGTATCA
GCGGAAAATAGCACGAATAC
AGGCAATCAGTGTAAAGGCA
CTTGTGCCAAATAACTCAACA
ATCAAAAGCCTGCTCAAATGA
CTTTCATGTCATCCATCATTG
TTGCTCTCGTGTGCCATCT

Supplementary Materials and Methods

Culture of group A streptococci. S. pyogenes strains were routinely propagated at 37
°C on horse blood agar (BioMérieux) or in static liquid cultures of Todd-Hewitt broth
(Difco) supplemented with 1% (w/v) yeast extract (THBY). Invasive GAS isolate
5448 (M1T1) and the isogenic animal-passaged SpeB-negative variant 5448AP have
been described previously11. The isogenic mutants 5448Δsda15, 5448ΔspeB11 and
GAS strain SF37019, have also been described previously.

Construction of recombinant GAS strains. Allelic exchange was used to precisely
replace the deleted sda1 chromosomal locus in 5448Δsda1 with the WT sda1 gene to
construct strain 5448RCsda1+. The technology employed to construct 5448RCsda1+
was similar to that used in the construction of 5448Δsda15. The PCR primers
RCSdapHY304Fwd and RCSdapHY304Rev were employed for amplification of
flanking DNA upstream and downstream of sda1 in the 5448 chromosome
(Supplementary Table 2). Following amplification, the sda1 gene was cloned by
PstI/EcoRI digestion and T4 ligation into the temperature-sensitive plasmid pHY3045.
The

resulting

plasmid

(pHYsda1)

was

transformed

into

5448∆sda1

by

electroporation. Integration of pHYsda1 into the chromosome via single-crossover
was achieved by culture at the permissive temperature for plasmid replication (30 ˚C).
Following subculture at 37 ˚C, single-crossover chromosomal insertions were selected
using chloramphenicol (∆sda1) and erythromycin (pHY304). Double-crossover was
achieved by serial passage at 30 ˚C, and double-crossover reverse-complemented
mutants were identified following removal of antibiotic selection. The reversecomplemented strain 5448RCsda1+ was characterized as sensitive to both

chloramphenicol and erythromycin; confirmed as sda1 PCR-positive using the
forward primer SdaF2 and reverse primer SdaR4 (Supplementary Table 2); and able
to express Sda1 upon assaying for DNase activity (as described below).

The isogenic 5448Δsmez mutant was constructed in a manner identical to 5448Δsda1,
as previously described5. A precise, in-frame allelic exchange replacement of the
smeZ gene in GAS strain 5448 with a chloramphenicol acetyltransferase (cat)
antibiotic resistance cassette was generated. The specific primer sets used for
amplification of the flanking DNA upstream and downstream of smeZ in the 5448
chromosome are given (Supplementary Table 2). The primers SmeZ-UpR and
SmeZ-DownF contain a 25 bp 5’ extension corresponding to the 5’ and 3’ ends of the
cat gene, respectively.

Integrational mutagenesis of ska and emm1 was performed essentially as previously
described20. Internal fragments of the genes ska and emm1 were PCR amplified from
GAS strain 5448 using specific primer pairs (Supplementary Table 2) and cloned by
BamHI/XbaI digestion and T4 ligation into the temperature-sensitive plasmid
pVE600721. The resultant plasmids were transformed into 5448AP by electroporation
and chloramphenicol resistant transformants were grown at the permissive
temperature for plasmid replication (30 ˚C). Single-crossover Campbell-type
chromosomal insertions were selected by shifting to the non-permissive temperature
(37 ˚C), while maintaining chloramphenicol selection. Integrational knockouts were
confirmed by PCR using the forward primer T7-For and reverse primer emm1out-R
or M1skaout-R (Supplementary Table 2). Confirmed integrational knockouts were
designated 5448APΔemm1 and 5448APΔska.

Molecular and phenotypic analysis of GAS. To screen GAS strains for mutations in
the covRS locus, we designed 12 primers for PCR and DNA sequence analysis
(Supplementary Table 3 and Fig. 1a). Firstly, primers p1 and p12 were used to PCR
amplify the intact covRS locus from genomic DNA which was extracted by phenolchloroform. Then, an ABI PRISM 7700 Sequence Detection System (Applied
Biosystems) was used to directly sequence the amplified PCR product with the 12
primers and the sequence assembled by the use of Sequencher version 4.5 (Gene
Codes Corporation). Using BLASTN analysis, the assembled sequences were aligned
against GAS genomes and a single adenine base insertion mutation was identified at
position 877 in the 5448AP covS gene, using numbering relative to the ATG start
codon of 5448 covS. Other in vivo-derived, SpeB-negative GAS strain 5448
derivatives were analyzed for covRS mutations in an identical manner.

SpeB-positive and SpeB-negative isolates were routinely identified by the Columbia
skim milk agar assay22. Quantitative SpeB assays were undertaken as previously
described23. Bacterial surface plasmin acquisition from human plasma assays and
western blot identification of α-enolase, GAPDH, streptokinase and M1 protein, were
conducted essentially as previously described4, with exception that cross-specific
rabbit M53 protein-specific serum was used to identify M1 protein. GAS strain
NS113324 was used as an internal control for bacterial surface plasmin acquisition
assays4 undertaken by incubating bacteria overnight in human plasma. Plasminogenbinding assays were conducted as previously described24.

Virulence of GAS in a humanized plasminogen transgenic mouse model.
Transgenic humanized plasminogen AlbPLG1 mice heterozygous for the human
plasminogen transgene16 were backcrossed greater than n = 6 with C57BL/J6 mice
(Animal Resources Centre, Perth, Australia). GAS strains 5448 and 5448AP were
harvested at logarithmic phase (OD600 approx. 0.4), washed twice with sterile 0.7%
saline and diluted to the required dose. The number of viable bacteria was determined
by counting colony forming units (CFU) after plating a dilution series onto blood
agar. The SpeB expression status of 5448 and 5448AP was also determined as
described above (n = 50). The 5448AP inoculum was found to be 100% SpeBnegative, while the 5448 inoculum was 100% SpeB-positive. Groups of AlbPLG1
mice (n = 10) were subcutaneously infected with GAS and mortality was monitored
for 10 d. Alternatively, groups of AlbPLG1 mice (n = 5) were subcutaneously infected
with either 5448 or 5448AP for 48 h and the lesion (site of infection), blood, spleen
and liver harvested. Lesion, spleen and liver samples were homogenized in 2 ml of
sterile 0.7% saline. The number of viable bacteria was determined by counting CFU
after plating a dilution series onto blood agar.

Isolation of mRNA and real-time PCR analysis. In order to isolate in vivo-derived
RNA, we utilized the subcutaneous Teflon chamber model25. Teflon chambers were
inserted surgically under the skin of 6-week-old female BALB/c mice. Three weeks
after surgery, tissue chamber fluid (TCF) was collected and tested for sterility. Mice
that had contaminated TCF, or those that had open surgical wounds, were excluded
from further experimentation. To prepare inocula, bacteria were grown overnight in
THBY, checked for SpeB phenotype as detailed above, then subcultured for 18 h in
THBY. Bacterial pellets were washed twice in sterile phosphate buffered saline (PBS)

and resuspended in sterile PBS to 1 × 109 CFU/ml. We injected 100 μl of this
bacterial suspension into the subcutaneous chambers using sterile 25-gauge needles.
At 24 h post-injection, sterile 25-gauge needles were used to collect the TCF to
analyze bacterial content and SpeB status, and to extract RNA from recovered
bacteria11,

25

. This 24 h time point was chosen as WT 5448 GAS recovered from

mouse infection chambers were > 95% SpeB-positive (data not shown), whereas after
3 d in vivo the WT subcutaneous bacterial population contain a significant proportion
(up to 74%) of SpeB-negative phenotype4. 5448AP cells recovered from 24 h
infection chambers were uniformly SpeB-negative. RNA was extracted from bacterial
pellets using RNeasy kits (Qiagen), treated with DNase (Ambion) for 1 h to remove
contaminating genomic DNA, and then recovered using RNeasy columns (Qiagen).
The absence of genomic DNA in the RNA samples was confirmed by PCR using
primers specific for the speB gene11 (data not shown). The intactness and purity of
isolated RNA was assessed using an Agilent Technologies Bioanalyzer (data not
shown). Superscript II (Invitrogen) was used to reverse transcribe RNA into cDNA,
following the manufacturer’s protocol; cDNA was immediately diluted with four
volumes of sterile water then aliquoted for real-time PCR reactions. We performed all
Sybr-Green real-time quantitative PCR reactions using an ABI PRISM 7700
Sequence Detection System (Applied Biosystems) and calculated relative expression
amounts using the delta-delta CT method11. All real-time PCR reactions were
performed using biological triplicates; product specificity was confirmed by the
presence of a single peak in dissociation curves. Fluorescence in all real-time
quantitative PCR reactions was measured at 75 ˚C, a temperature at which any
potential primer dimers would melt, ensuring that the PCR product measured was the

expected product. Primers used for real-time PCR analysis of speB and sda1 have
been previously described11, 26.

DNase activity assays. Supernatants were collected from mid-logarithmic (OD600 =
0.4) or stationary phase cultures of GAS strains grown in THBY. Calf thymus DNA
(1.0 μg/μl) was combined with bacterial supernatant (2.5 μl) in final volume of 50 μl
buffer (300 mM Tris, 3 mM CaCl2, 3 mM MgCl2) for 15 min at room temperature. To
halt DNase activity, 12.5 μl of 0.33 M EDTA was added to the reaction. Visualization
of relative DNA degradation was undertaken by side-by-side comparison of DNA
using 1% agarose gel electrophoresis.

Live cell imaging for visualization of NETs. NETs were visualized as previously
described5. Briefly, neutrophils were seeded at 2 × 105 per well in 96-well plates in
RPMI without phenol red (Invitrogen). GAS were added to the wells at a multiplicity
of infection of 1:100 (GAS:neutrophils) and Sytox Orange (Molecular Probes) added
to a final concentration of 0.1 μM. Cells were visualized without fixation or washed
using a Zeiss Axiovert 100 inverted microscope with appropriate fluorescent filters,
and images captured with a CCD camera. For quantitation, NETs were enumerated
for each treatment by counting three fields of view after staining from three
independent wells; a NET was defined as a discrete area of bright orange fluorescence
larger in size than a neutrophil. Presented data are representative of experiments
undertaken on three separate occasions.

Neutrophil killing assays. Neutrophil killing assays were performed as previously
described5. Briefly, human neutrophils were isolated and purified from venous blood

using the PolyMorphPrep kit (Axis-Shield) as per the manufacturer’s instructions and
seeded into 96-well plates at 2 × 105 cells/well. Logarithmic-phase bacteria grown in
THBY were diluted to the desired concentration in RPMI media containing 2% heat
inactivated autologous human plasma, then added to neutrophils at a multiplicity of
infection of 1:10 (GAS:neutrophils). Plates were centrifuged at 500 × g for 10 min
then incubated at 37 °C in 5% CO2. Following incubation for 1 h, neutrophils were
lysed with 0.02% Triton X-100 and the contents of the well serially diluted and plated
on Todd-Hewitt agar for overnight incubation and enumeration of CFU. Internal
control wells without neutrophils were used to determine baseline bacterial counts at
the assay endpoints. Percent survival of GAS was calculated as ([CFU/ml
experimental well] / [CFU/ml control well]) × 100%. All assays were performed in
triplicate.

Monitoring the in vivo phase-shift of GAS strains. Separate cohorts of C57BL/J6
mice (n = 10) were inoculated subcutaneously with a non-lethal dose of GAS to
examine the in vivo phase-shift of SpeB during infection. The inocula used in these
experiments were plated out onto blood agar plates then individual colonies tested for
SpeB expression status as described above (n = 50). The 5448, 5448Δsda1,
5448RCsda1+ and 5448Δsmez inocula were found to be 100% SpeB-positive. On day
three post-infection, mice were sacrificed by CO2 asphyxiation and representative
bacteria isolated from skin lesions4. The SpeB status of individual colonies (n = 50)
was determined as described above.

All animal experiments were conducted according to the Guidelines for the Care and
Use of Laboratory Animals (National Health and Medical Research Council,

Australia) and were approved by the University of Wollongong Animal Ethics
Committee.

Statistical analyses. Statistical analysis of SpeB expression and status, plasminogenbinding, surface plasmin activity, quantitative real-time PCR, human neutrophil
killing assays, and NET quantification were performed using a one way ANOVA with
a Dunnett’s Multiple Comparison Test. Differences were considered statistically
significant at P < 0.05. Differences in survival of humanized plasminogen transgenic
mice infected with GAS strains 5448, 5448AP and 5448APΔska were determined by
the log-rank test. All statistical tests were performed using GraphPad Prism version
4.02.

